WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC

Holdings History for TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI)

Symbol: TMCI on Nasdaq
Investment type: Equity / Common stock, $0.001 par value
Latest Disclosed Shares Owned: 1,145,498 shares
Security Ownership %: 1.8%

Shares, Excluding Options vs Price

Value, Excluding Options

WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC ownership in TREACE MEDICAL CONCEPTS, INC. Common stock, $0.001 par value (TMCI)

09 Feb 2026 - WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1,145,498 shares of TREACE MEDICAL CONCEPTS, INC. Common stock, $0.001 par value (TMCI). This represents 1.8% ownership of the company. In their previous filing dated 12 Nov 2025, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC had reported owning 3,664,472 shares, indicating a decrease of +69%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC	1.8%	-67%	$2,863,745	1,145,498	-2,518,974	-69%	$2.50	13G/A	31 Dec 2025	09 Feb 2026, 15:13
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC	5.8%		$24,588,607	3,664,472			$6.71	13G	30 Sep 2025	12 Nov 2025, 17:54

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.01%	-0.02%	$2,806,470	1,145,498	-2,488,883	-68%	$2.45	Q4 2025
30 Sep 2025	0.06%	+0.01%	$24,386,697	3,634,381	+534,486	+17%	$6.71	Q3 2025
30 Jun 2025	0.05%	+0%	$18,227,383	3,099,895	+39,283	+1.3%	$5.88	Q2 2025
31 Mar 2025	0.07%	+0%	$25,678,535	3,060,612	+121,764		$8.39	Q1 2025
31 Dec 2024	0.05%	+0.01%	$21,865,029	2,938,848	+546,787	+23%	$7.44	Q4 2024
30 Sep 2024	0.03%	-0.02%	$13,873,954	2,392,061	-1,289,657	-35%	$5.80	Q3 2024
30 Jun 2024	0.06%	+0.02%	$24,483,425	3,681,718	+1,352,207	+58%	$6.65	Q2 2024
31 Mar 2024	0.08%	-0.02%	$30,400,119	2,329,511	-538,523	-19%	$13.05	Q1 2024
31 Dec 2023	0.11%	+0.04%	$36,567,434	2,868,034	+1,082,033	+61%	$12.75	Q4 2023
30 Sep 2023	0.08%	+0.04%	$23,414,473	1,786,001	+811,777	+83%	$13.11	Q3 2023
30 Jun 2023	0.08%	+0%	$24,920,650	974,224	+11,297	+1.2%	$25.58	Q2 2023
31 Mar 2023	0.08%	+0.02%	$24,256,131	962,927	+234,160	+32%	$25.19	Q1 2023
31 Dec 2022	0.06%	+0.01%	$16,754,353	728,767	+162,447	+29%	$22.99	Q4 2022
30 Sep 2022	0.05%	-0.02%	$12,499,000	566,320	-252,353	-31%	$22.07	Q3 2022
30 Jun 2022	0.04%	+0.04%	$11,740,000	818,673	+818,673	NEW	$14.34	Q2 2022

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.